Clinical trial
Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis
NCT04750135 is registered in ClinicalTrials.gov with National Hepatology & Tropical Medicine Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis
- Lead sponsor
- National Hepatology & Tropical Medicine Research Institute
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- February 7, 2021
- Completion date
- June 1, 2021
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel diseases, ulcerative colitis